Survival in Pulmonary Hypertension with Diabetes
Treatments studied
Part of Hormones & metabolism, Lungs & breathing clinical trials.
This study looks at how diabetes affects long-term survival in people with pulmonary hypertension (high blood pressure in the lungs). It aims to find factors that may help or harm your health over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have been diagnosed with pulmonary hypertension (high blood pressure in the lungs).
- You do not have any active cancer (malignant tumor).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how things in your environment (like pollution, diet, or lifestyle) might be linked to pulmonary hypertension. By comparing two groups of patients, researchers hope to find new clues about the condition.
This observational study is looking at people diagnosed with pulmonary hypertension to better understand how it behaves over time. You may help researchers by allowing repeated check-ins for years and sharing symptom and test information.
This study tests if the diabetes drug empagliflozin can help people with pulmonary arterial hypertension (PAH), a condition causing high blood pressure in the lungs. It aims to see if the drug improves symptoms and is safe for patients with moderate symptoms.
This study tracks natural changes in “biomarkers” (measurable signals in blood) and imaging findings in people with pulmonary arterial hypertension (PAH) or suspected PAH. It also includes healthy people for comparison, helping researchers understand what these signals mean over time.
This study aims to better predict the future risk for people with pulmonary hypertension (high blood pressure in the lungs) by combining different types of health information collected over time. If you join, researchers will track your health data to build a tool that personalizes care and improves outcomes.
This study tests whether using a mobile health tool can help people with pulmonary arterial hypertension (PAH) manage their condition in daily life. It’s aimed at adults who are stable on their PAH medicines and can track activity using a wearable device.
Hear when a new Pulmonary Arterial Hypertension (PAH) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.